Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05244447 · ClinicalTrials.gov registry record · NA

IVROP ReadyforLIFE Program Evaluation

A NA study of Youth, sponsored by Midwest Evaluation & Research.

Completed
Registry status
NA
Development phase
1,054
Enrollment target
1
Study location

NCT05244447 is a NA study of Youth that has completed, run by Midwest Evaluation & Research. The registered enrollment target is 1,054 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05244447, a NA study of Youth, has completed, sponsored by Midwest Evaluation & Research.

COMPLETED
Registry status
NA
Development phase
1,054 participants
Enrollment target
1
Study location

Study Summary

The purpose of the Imperial Valley Regional Occupational Program (IVROP) ReadyforLIFE program evaluation is to determine whether primary (i.e., behaviors) and secondary (i.e., attitudes) outcomes improve for youth participants after completing the ReadyforLIFE program. Understanding the ways in which the IVROP ReadyforLIFE program supports healthy partner relationships and economic stability is important for those providing services to at-risk youth populations.

Conditions Studied

Interventions

  • OTHER Primary Services

Study Locations (1)

California

  • Imperial Valley Regional Occupational Program Community Foundation (IVROPCF) - El Centro

Trial Details

FieldValue
Enrollment Target 1,054 participants
Start Date 2021-04-01
Est. Completion 2025-02-01
Phase NA

Sponsor

Midwest Evaluation & Research

12 total trials

What the Registry Record Tells You About NCT05244447

The ClinicalTrials.gov registry entry for NCT05244447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,054 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Midwest Evaluation & Research, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Youth appearing as the primary indexed condition, and to 1 intervention - of which Primary Services is the first listed.

NCT05244447 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05244447 about?

NCT05244447 is a clinical study titled "IVROP ReadyforLIFE Program Evaluation". The purpose of the Imperial Valley Regional Occupational Program (IVROP) ReadyforLIFE program evaluation is to determine whether primary (i.e., behaviors) and secondary (i.e., attitudes) outcomes improve for youth participants after completing the ReadyforLIFE program. Understanding the ways in whic...

What is the current status of trial NCT05244447?

This trial is currently completed. It is a NA study. The enrollment target is 1,054 participants. The study started on 2021-04-01. Estimated completion is 2025-02-01.

What conditions does trial NCT05244447 study?

This clinical trial studies the following conditions: Youth.

What interventions are being tested in trial NCT05244447?

The interventions under investigation include: Primary Services (OTHER).

Who is sponsoring clinical trial NCT05244447?

This trial is sponsored by Midwest Evaluation & Research, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05244447 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Youth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.